Abstract
Unexpected abdominal activity was registered later than 1 h post injection in technetium-99m bone marrow scintigrams of 13 multiple myeloma patients and of five controls. The activity was considered to be localised in the gastro-intestinal tract. It is attributed to accumulation of degradation products of the used nanocolloid tracer. Corresponding results are known in patients with inflammatory bowel disease when scintigraphy is performed with other radiopharmaceuticals.
This is a preview of subscription content, log in via an institution to check access.
References
Ranner GV, Fueger GF, Hörmann M. Ergebnisse der Knochenmarkszintigraphie bei hämatologischen Erkrankungen.Fortschr Röntgenstr 1987; 146: 300–305.
Vorne M, Lantto T, Paakkinen S, Salo S, Soini I. Clinical comparison of 99mTc-HMPAO labeled leucocytes and 99mTc-nanocolloid in the detection of inflammation.Acta Radiol 1989; 30: 633–637.
Wheeler JG, Slack NF, Duncan A, Palmer M, Harvey RE99mTc-nanocolloid imaging in inflammatory bowel disease.Nucl Med Commun 1990; 11: 127–133.
Arndt J-W, Sluys-Veer A van de, Blok D, Griffoen G, Verspaget HW, Pena S, Lamers BHW, Pauwels EKJ. Technetium99m nanocolloid for the scintigraphic assessment of inflammatory bowel disease in the colon: its value in comparison with indium-111-labelled granulocytes.Eur J Radiol 1991; 10: 30–34.
Kalin B, Sellin P, Krusenstierna SV, Schnell P-O, Jacobsson H. Effect of size fractionation on the distribution of an albumin colloid in the reticuloendothelial system of the mouse.Nucl Med Biol 1991; 18: 817–820.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ågren, B., Måre, K. & Aspelin, P. Gastrointestinal activity following bone marrow scintigraphy with technetium-99m nanocolloid in patients with multiple myeloma. Eur J Nucl Med 22, 1319–1322 (1995). https://doi.org/10.1007/BF00801620
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00801620